Moreover, both gain and loss-of-function models involving IL-33 or ST2 have demonstrated specific alterations to the Treg populations in VAT, indicating IL-33/ST2 axis as a crucial mechanism to control Treg populations during obesity (21, 34–36). Here, IL1RL1 is linked to obesity disorder.